Possible Strategies to Mitigate Placebo or Vehicle Response in Dry Eye Disease Trials: A Narrative Review

Many candidate drugs for dry eye disease (DED) have been assessed over the years in pursuit of demonstrating efficacy in both signs and symptoms. However, patients with DED have very limited treatment options for management of both signs and symptoms of DED. There are several potential reasons behin...

Descripción completa

Detalles Bibliográficos
Autores principales: Montecchi-Palmer, Michela, Wu, Min, Rolando, Maurizio, Lau, Charis, Perez Quinones, Victor L., Dana, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287883/
https://www.ncbi.nlm.nih.gov/pubmed/37208548
http://dx.doi.org/10.1007/s40123-023-00720-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287883/
https://www.ncbi.nlm.nih.gov/pubmed/37208548
http://dx.doi.org/10.1007/s40123-023-00720-1

Ejemplares similares